Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

33 trials with published results (10%)

Research Maturity

158 completed trials (47% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.3%

21 terminated out of 336 trials

Success Rate

88.3%

+1.8% vs benchmark

Late-Stage Pipeline

8%

28 trials in Phase 3/4

Results Transparency

21%

33 of 158 completed with results

Key Signals

33 with results88% success21 terminated

Data Visualizations

Phase Distribution

193Total
Not Applicable (116)
P 1 (26)
P 2 (23)
P 3 (8)
P 4 (20)

Trial Status

Completed158
Unknown77
Recruiting39
Terminated21
Not Yet Recruiting16
Withdrawn10

Trial Success Rate

88.3%

Benchmark: 86.5%

Based on 158 completed trials

Clinical Trials (336)

Showing 20 of 20 trials
NCT07646015Completed

Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders

NCT06336850Not ApplicableCompletedPrimary

Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement

NCT07634939Not Yet RecruitingPrimary

Liver Micro Flow - MRI

NCT04181138Recruiting

Primary Sclerosing Cholangitis in Children

NCT00571272SuspendedPrimary

Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC)

NCT05272319CompletedPrimary

Genetic Collection Protocol

NCT03265249Not ApplicableTerminated

BRIDGE Device for Post-operative Pain Control

NCT07602504Recruiting

China Metastatic Liver Cancer Clinical Registry Cohort Database

NCT03773887Not ApplicableRecruitingPrimary

Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease

NCT07524699Not ApplicableNot Yet RecruitingPrimary

A Study About Remote and Local Liver Surgery

NCT07111130Not ApplicableNot Yet RecruitingPrimary

Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer

NCT07580482Not ApplicableCompletedPrimary

The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate Referral

NCT07150624Phase 4Recruiting

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

NCT05255042CompletedPrimary

Tissue Models for Liver Disease

NCT02908048Terminated

Extracellular RNA Markers of Liver Disease and Cancer

NCT07559474Phase 1Not Yet Recruiting

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

NCT07028112Recruiting

Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.

NCT06874296Not ApplicableRecruiting

Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time

NCT06278883Not ApplicableCompleted

Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase

NCT00345930RecruitingPrimary

DILIN - Prospective Study

Scroll to load more

Research Network

Activity Timeline